Veterinary Surgical Oncology. Группа авторов
Читать онлайн книгу.
intermediate‐ to high‐grade lymphoma with a modified university of Wisconsin‐Madison protocol: 119 cases (2004–2012). Vet Comp Oncol. 14(1):136–146.
138 Constantino‐Casas, F., D. Mayhew, T.M. Hoather, et al. 2011. The clinical presentation and histopathologic‐immunohistochemical classification of histiocytic sarcomas in the Flat Coated Retriever. Vet Pathol 48:764–771.
139 Coomer, A., J. Farese, R. Milner, et al. 2009. Radiation therapy for canine appendicular osteosarcoma. Vet Comp Oncol 7:15–27.
140 Cooper, M., X. Tsai, and P. Bennett. 2009. Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases. Vet Comp Oncol 7:196–206.
141 Cotter, S.M. and M.A. Goldstein. 1983. Treatment of lymphoma and leukaemia with cyclophosphamide, vincristine and prednisolone: I Treatment of the dog. J Am Anim Hosp Assoc 19:159–165.
142 Covey, J.L., J.P. Farese, N.J. Bacon, et al. 2014. Stereotactic radiosurgery and fracture fixation in 6 dogs with appendicular osteosarcoma. Vet Surg 43:174–181.
143 Craig, L.E., M.E. Julian, and J.D. Ferracone. 2002. The diagnosis and prognosis of synovial tumors in dogs: 35 cases. Vet Pathol 39:66–73.
144 Cristofanilli, M., A.U. Buzdar, N. Sneige, et al. 2001. Paclitaxel in the multimodality treatment for inflammatory breast carcinoma. Cancer 92:1775–1782.
145 Cronin, K., R.L. Page, G. Spodnick, et al. 1998. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 39:51–56.
146 Crow, S.E., G.H. Theilen, E. Benjaminini, et al. 1977. Chemoimmunotherapy for canine lymphosarcoma. Cancer 40:2102–2108.
147 Culbertson, M.R., Jr. 1982. Hemangiosarcoma of the canine skin and tongue. Vet Pathol 19:556–558.
148 Culp, W.T., C.M. Macphail, J.A. Perry, et al. 2011. Use of a nitinol stent to palliate a colorectal neoplastic obstruction in a dog. J Am Vet Med Assoc 239:222–227.
149 Culp, W.T., C. Weisse, A.C. Berent, et al. 2015. Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs. J Vet Intern Med 29:900–907.
150 Cunha, S.C., K.B. Corgozinho, H.J. Souza, et al. 2015. Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy. J Feline Med Surg 17:1000–1004.
151 Curran, K.M., C.H. Halsey, and D.R. Worley. 2016. Lymphangiosarcoma in 12 dogs: A case series (1998–2013). Vet Comp Oncol 14(2):181–190.
152 Curran, K. and D.H. Thamm. 2016. Retrospective analysis for treatment of naive canine multicentric lymphoma with a 15‐week, maintenance‐free CHOP protocol. Vet Comp Oncol. 14 Suppl 1:147–155.
153 Daminet, S., H.S. Kooistra, F. Fracassi, et al. 2014. Best practice for the pharmacological management of hyperthyroid cats with antithyroid drugs. J Small Anim Pract 55:4–13.
154 Dank, G., K.M. Rassnick, Y. Sokolovsky, et al. 2014. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision. Vet Comp Oncol 12:78–84.
155 Danova, N.A., J.C. Robles‐Emanuelli, and D.E. Bjorling. 2006. Surgical excision of primary canine rectal tumors by an anal approach in twenty‐three dogs. Vet Surg 35:337–340.
156 Daters, A.T., G.E. Mauldin, G.N. Mauldin, et al. 2010. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP‐MA) for the treatment of canine lymphoma. Vet Comp Oncol 8:11–22.
157 Davidson, E.B., C.R. Gregory, and P.H. Kass. 1997. Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg 26:265–269.
158 Davies, D.R., K.M. Wyatt, J.E. Jardine, et al. 2004. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 40:124–130.
159 De Lorenzi, D., D. Bertoncello, and A. Dentini. 2015. Intraoral diode laser epiglottectomy for treatment of epiglottis chondrosarcoma in a dog. J Small Anim Pract 56:675–678.
160 De Souza, C.H.M., E. Toledo‐Piza, R. Amorin, et al. 2009. Inflammatory mammary carcinoma in 12 dogs: Clinical features, cyclooxygenase‐2 expression, and response to piroxicam treatment. Can Vet J 50:506–510.
161 De Vos, J., S. Ramos Vega, E. Noorman, et al. 2012. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib. Vet Comp Oncol 10:206–213.
162 Demetriou, J.L., M.J. Brearley, F. Constantino‐Casas, et al. 2012. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy. J Small Anim Pract 53:174–181.
163 Dernell, W.S., R.C. Straw, M.F. Cooper, et al. 1998a. Multilobular osteochondrosarcoma in 39 dogs: 1979–1993. J Am Anim Hosp Assoc 34:11–18.
164 Dernell, W.S., S.J. Withrow, C.A. Kuntz, et al. 1998b. Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 13:59–64.
165 Dervisis, N.G., P.A. Dominguez, R.G. Newman, et al. 2011. Treatment with DAV for advanced‐stage hemangiosarcoma in dogs. J Am Anim Hosp Assoc 47:170–178.
166 Dervisis, N.G., P.A. Dominguez, L. Sarbu, et al. 2007. Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma. J Am Vet Med Assoc 231:563–569.
167 Dervisis, N.G. and B.E. Kitchell. 2010. Dacarbazine as single‐agent therapy for relapsed lymphoma in dogs. J Vet Intern Med 24:4; author reply 5.
168 Dhawan, D., J.A. Ramos‐Vara, J.F. Naughton, et al. 2013. Targeting folate receptors to treat invasive urinary bladder cancer. Cancer Res 73:875–884.
169 Dobson, J., S. Cohen, and S. Gould. 2004. Treatment of canine mast cell tumours with prednisolone and radiotherapy. Vet Comp Oncol 2:132–141.
170 Donnelly, L., C. Mullin, J. Balko, et al. 2015. Evaluation of histological grade and histologically tumour‐free margins as predictors of local recurrence in completely excised canine mast cell tumours. Vet Comp Oncol 13:70–76.
171 Dougherty, T.J., R.E. Thoma, D.G. Boyle, et al. 1981. Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. Cancer Res 41:401–404.
172 Dow, S.W., R.E. Elmslie, A.P. Willson, et al. 1998. in vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest 101:2406–2414.
173 Drake, D.B. and S.N. Oishi. 1995. Wound healing considerations in chemotherapy and radiation therapy. Clin Plast Surg 22:31–37.
174 Drazner, F.H. 1982. Multiple myeloma in the cat. Comp Contin Educ 4:206–216.
175 Dunning, D., E. Monnet, E.C. Orton, et al. 1998. Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985–1996). J Am Vet Med Assoc 212:1276–1280.
176 Eckstein, C., F. Guscetti, M. Roos, et al. 2009. A retrospective analysis of radiation therapy for the treatment of feline vaccine‐associated sarcoma. Vet Comp Oncol 7:54–68.
177 Ehrhart, N. 2005a. Longitudinal bone transport for treatment of primary bone tumors in dogs: Technique description and outcome in 9 dogs. Vet Surg 34:24–34.
178 Ehrhart, N. 2005b. Soft‐tissue sarcomas in dogs: A review. J Am Anim Hosp Assoc 41:241–246.
179 Ehrhart, N.P., J.A. Eurell, P.D. Constable, et al. 2005. The effect of host tissue irradiation on large‐segment allograft incorporation. Clin Orthop Relat Res 435:43–‐51.
180 Ehrhart, N.P., S.D. Ryan, and T.M. Fan. 2013. 24 – Tumors of the skeletal system. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.
181 Eisenschenk, A., C. Witzel, M. Lautenbach, et al. 2006. Impact of radiation therapy on healing and stability of vascularized bone grafts in a dog model. Microsurgery 26:412–416.
182 Elliott, J.W., P. Cripps, A.M. Marrington, et al. 2013. Epirubicin as part of a multi‐agent